Surgery Partners (NASDAQ:SGRY) Research Coverage Started at KeyCorp

KeyCorp started coverage on shares of Surgery Partners (NASDAQ:SGRYFree Report) in a report issued on Friday morning, Marketbeat Ratings reports. The firm issued a sector weight rating on the stock. KeyCorp also issued estimates for Surgery Partners’ FY2024 earnings at $0.81 EPS.

A number of other brokerages have also recently weighed in on SGRY. Citigroup reduced their price objective on Surgery Partners from $38.00 to $36.00 and set a buy rating for the company in a research note on Wednesday, August 7th. Benchmark restated a buy rating and issued a $50.00 target price on shares of Surgery Partners in a research note on Monday, August 26th. Cantor Fitzgerald reiterated an overweight rating and set a $43.00 price target on shares of Surgery Partners in a research note on Friday, October 4th. Macquarie started coverage on Surgery Partners in a report on Friday, June 28th. They issued an outperform rating and a $31.00 price objective on the stock. Finally, Royal Bank of Canada reissued an outperform rating and set a $49.00 target price on shares of Surgery Partners in a research note on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Surgery Partners presently has a consensus rating of Moderate Buy and a consensus price target of $39.86.

Check Out Our Latest Research Report on Surgery Partners

Surgery Partners Stock Up 0.4 %

Shares of Surgery Partners stock opened at $30.46 on Friday. Surgery Partners has a 52-week low of $22.05 and a 52-week high of $36.92. The company has a 50 day moving average of $30.79 and a 200 day moving average of $27.83. The company has a market capitalization of $3.87 billion, a P/E ratio of -112.81, a P/E/G ratio of 2.33 and a beta of 2.75. The company has a quick ratio of 1.69, a current ratio of 1.83 and a debt-to-equity ratio of 0.96.

Surgery Partners (NASDAQ:SGRYGet Free Report) last posted its earnings results on Tuesday, August 6th. The company reported $0.21 EPS for the quarter, beating analysts’ consensus estimates of $0.20 by $0.01. Surgery Partners had a negative net margin of 1.17% and a positive return on equity of 2.96%. The firm had revenue of $762.10 million for the quarter, compared to the consensus estimate of $735.94 million. During the same period last year, the firm posted $0.25 EPS. The company’s revenue was up 14.2% on a year-over-year basis. As a group, research analysts forecast that Surgery Partners will post 0.86 EPS for the current fiscal year.

Institutional Trading of Surgery Partners

Several large investors have recently bought and sold shares of the company. Creative Planning purchased a new stake in Surgery Partners in the 3rd quarter valued at approximately $258,000. Handelsbanken Fonder AB increased its position in Surgery Partners by 35.1% during the third quarter. Handelsbanken Fonder AB now owns 18,100 shares of the company’s stock worth $584,000 after purchasing an additional 4,700 shares during the last quarter. Clearbridge Investments LLC boosted its holdings in Surgery Partners by 1.3% in the second quarter. Clearbridge Investments LLC now owns 5,585,530 shares of the company’s stock valued at $132,880,000 after acquiring an additional 73,007 shares during the last quarter. Quarry LP grew its holdings in shares of Surgery Partners by 133.1% during the 2nd quarter. Quarry LP now owns 3,082 shares of the company’s stock worth $73,000 after purchasing an additional 1,760 shares during the period. Finally, MidWestOne Financial Group Inc. raised its stake in shares of Surgery Partners by 17.1% in the 2nd quarter. MidWestOne Financial Group Inc. now owns 70,786 shares of the company’s stock valued at $1,684,000 after acquiring an additional 10,340 shares during the period.

Surgery Partners Company Profile

(Get Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Further Reading

Analyst Recommendations for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.